Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowland

Showing results (311-320 of 329) with videos related to

Pageof 33
Sort By:
Archives of Neurology|September 17, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Neurorehabilitation and Neural Repair|December 18, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Muscle & Nerve|October 1, 1996
Motor neuron disease, lymphoproliferative disease, and bone marrow biopsyE D Louis, A E Hanley, T H Brannagan, et al.
Annals of Neurology|November 30, 2005
Prion protein codon 129 genotype prevalence is altered in primary progressive aphasiaXiaohong Li, Lewis P Rowland, Hiroshi Mitsumoto, et al.
Journal of the Neurological Sciences|March 4, 2008
A novel tRNA(Val) mitochondrial DNA mutation causing MELASKurenai Tanji, Petra Kaufmann, Ali B Naini, et al.
Bone Marrow Transplantation|July 13, 2010
Biomarkers of immune activation to screen for severe, acute GVHDK J August, K-Y Chiang, R M Bostick, et al.
Neurology|June 1, 1997
Lymphoproliferative disorders and motor neuron disease: an updateP H Gordon, L P Rowland, D S Younger, et al.
Neurology|January 5, 2002
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994T Lynch, M Sano, K S Marder, et al.
Blood|July 29, 2025
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AMLRithin Nedumannil, Michael Ashby, James P Rowland, et al.
Neurology|April 12, 2006
Randomized controlled phase II trial of glatiramer acetate in ALSP H Gordon, C Doorish, J Montes, et al.
Pageof 33

Showing results (311-320 of 329) with videos related to

Sort By:
Pageof 33
Archives of Neurology|September 17, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Neurorehabilitation and Neural Repair|December 18, 2003
At jeopardy: the NIH as we know itRoger N Rosenberg, Timothy A Pedley, J Richard Baringer, et al.
Muscle & Nerve|October 1, 1996
Motor neuron disease, lymphoproliferative disease, and bone marrow biopsyE D Louis, A E Hanley, T H Brannagan, et al.
Annals of Neurology|November 30, 2005
Prion protein codon 129 genotype prevalence is altered in primary progressive aphasiaXiaohong Li, Lewis P Rowland, Hiroshi Mitsumoto, et al.
Journal of the Neurological Sciences|March 4, 2008
A novel tRNA(Val) mitochondrial DNA mutation causing MELASKurenai Tanji, Petra Kaufmann, Ali B Naini, et al.
Bone Marrow Transplantation|July 13, 2010
Biomarkers of immune activation to screen for severe, acute GVHDK J August, K-Y Chiang, R M Bostick, et al.
Neurology|June 1, 1997
Lymphoproliferative disorders and motor neuron disease: an updateP H Gordon, L P Rowland, D S Younger, et al.
Neurology|January 5, 2002
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994T Lynch, M Sano, K S Marder, et al.
Blood|July 29, 2025
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AMLRithin Nedumannil, Michael Ashby, James P Rowland, et al.
Neurology|April 12, 2006
Randomized controlled phase II trial of glatiramer acetate in ALSP H Gordon, C Doorish, J Montes, et al.
Pageof 33